Abstract:Synthetic modified messenger RNA (mRNA) has manifested great potentials for therapeutic applications such as vaccines and gene therapies, with the recent mRNA vaccines for global pandemic COVID-19 (corona virus disease 2019) attracting the tremendous attention. The chemical modifications and delivery vehicles of synthetic mRNAs are the two key factors for their in vivo therapeutic applications. Chemical modifications like nucleoside methylation endow the synthetic mRNAs with high stability and reduced stimulation of innate immunity. The development of scalable production of synthetic mRNA and efficient mRNA formulation and delivery strategies in recent years have remarkably advanced the field. It is worth noticing that we had limited knowledge on the roles of mRNA modifications in the past. However, the last decade has witnessed not only new discoveries of several naturally occurring mRNA modifications but also substantial advances in understanding their roles on regulating gene expression. It is highly necessary to reconsider the therapeutic system made by synthetic modified mRNAs and delivery vectors. In this review, we will mainly discuss the roles of various chemical modifications on synthetic mRNAs, briefly summarize the progresses of mRNA delivery strategies, and highlight some latest mRNA therapeutics applications including infectious disease vaccines, cancer immunotherapy, mRNA-based genetic reprogramming and protein replacement, mRNA-based gene editing. STATEMENT OF SIGNIFICANCE: The development of synthetic mRNA drug holds great promise but lies behind small molecule and protein drugs largely due to the challenging issues regarding its stability, immunogenicity and potency. In the last 15 years, these issues have beensubstantially addressed by synthesizing chemically modified mRNA and developing powerful delivery systems; the mRNA therapeutics has entered an exciting new era begun with the approved mRNA vaccines for the COVID-19 infection disease. Here, we provide recent progresses in understanding the biological roles of various RNA chemical modifications, in developing mRNA delivery systems, and in advancing the emerging mRNA-based therapeutic applications, with the purpose to inspire the community to spawn new ideas for curing diseases.

mRNA therapeutics for disease therapy: principles, delivery, and clinical translation

Development of Polypeptide-Based Materials Toward Messenger RNA Delivery

RNA-based Therapeutics: an Overview and Prospectus

Delivering the Messenger: Advances in Technologies for Therapeutic Mrna Delivery

Engineered mRNA Delivery Systems for Biomedical Applications

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications

Pharmaceutical strategies for optimized mRNA expression

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications

From structural design to delivery: mRNA therapeutics for cancer immunotherapy

Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery

Path towards mRNA delivery for cancer immunotherapy from bench to bedside

Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

mRNA-based therapeutics: looking beyond COVID-19 vaccines

The roles of polymers in mRNA delivery

The landscape of mRNA nanomedicine

Synthetic modified messenger RNA for therapeutic applications

Recent Advancements in mRNA Vaccines: From Target Selection to Delivery Systems

mRNA vaccines in disease prevention and treatment

Targeting Strategies for Site-Specific mRNA Delivery

Unlocking the promise of mRNA therapeutics